eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Residual Drug in Transdermal and Related Drug Delivery Systems; Availability
Residual Drug in Transdermal and Related Drug Delivery Systems; Availability
Document ID:
FDA-2010-D-0246-0001
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2010-19041
View Document:
Details Information
Document Subtype:
N-Notice
Received Date:
August 02 2010, at 12:00 AM Eastern Daylight Time
Start-End Page:
45640 - 45641
Page Count:
2
Comment Start Date:
August 3 2010, at 12:00 AM Eastern Standard Time
Comment Due Date:
November 1 2010, at 11:59 PM Eastern Standard Time
Comments
View All
Total:
10
Boehringer Ingelheim Pharmaceuticals, Inc. - Comment
Posted:
10/27/2010
ID:
FDA-2010-D-0246-0003
Comment Period Closed
Nov 01,2010 11:59 PM ET
GlaxoSmithKline - Comment
Posted:
10/27/2010
ID:
FDA-2010-D-0246-0005
Comment Period Closed
Nov 01,2010 11:59 PM ET
Mylan Technologies Inc. - Comment
Posted:
11/02/2010
ID:
FDA-2010-D-0246-0006
Comment Period Closed
Nov 01,2010 11:59 PM ET
Biotechnology Industry Organization (BIO - Comment
Posted:
11/02/2010
ID:
FDA-2010-D-0246-0007
Comment Period Closed
Nov 01,2010 11:59 PM ET
Pfizer Inc. - Comment
Posted:
11/02/2010
ID:
FDA-2010-D-0246-0008
Comment Period Closed
Nov 01,2010 11:59 PM ET
Related Documents
Total:
0
No documents available.
Residual Drug in Transdermal and Related Drug Delivery Systems; Availability
Details Information
Comments
View AllPosted: 10/27/2010 ID: FDA-2010-D-0246-0003
Nov 01,2010 11:59 PM ET
Posted: 10/27/2010 ID: FDA-2010-D-0246-0005
Nov 01,2010 11:59 PM ET
Posted: 11/02/2010 ID: FDA-2010-D-0246-0006
Nov 01,2010 11:59 PM ET
Posted: 11/02/2010 ID: FDA-2010-D-0246-0007
Nov 01,2010 11:59 PM ET
Posted: 11/02/2010 ID: FDA-2010-D-0246-0008
Nov 01,2010 11:59 PM ET
Related Documents